Keywords: allergan, income, soars, 2nd-qtr, drugmaker, says, increase
Allergan's income soars 86% in 2nd-qtr
Article | 13 August 2007
US drugmaker Allergan says that a 23.2% increase in revenues to $988.1 million, increased earnings some 85.7% to $137.8 million in the three months ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
